Trial
NCT00982995
Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
—
Condition
Nausea
Intervention
Palonosetron
Why stopped
site terminated due to lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-04